Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population].

Medicina clinica - 9 Oct 2004

Ejarque Ismael, Real José T, Chaves Felipe J, Blesa Sebastián, González Verónica, Milian Enrique, Ascaso Juan F, Priego María A, Carmena Rafael

Abstract excerpt

BACKGROUND AND OBJECTIVE: To compare the lipoprotein phenotype between FDB and heterozygous familial hypercholesterolemia (FH); to study the prevalence and possible founder effect of familial ligand-defective apo B100 (FDB) in a Mediterranean population, and to analyze the clinical and biochemical characteristics of FDB patients. SUBJECTS AND METHOD: We studied 19 heterozygous FDB subjects (8 males) from 12...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoprotein B-100

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Apolipoproteins B

Share to Founder Effect

Share to Hyperlipoproteinemia Type II

Share to Lipoproteins

Share to Mediterranean Region

Share to Phenotype

Source

Identifiers

PMID: 15498441
DOI: 10.1016/s0025-7753(04)74554-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinical and biochemical characteristics of familial ligand-defective apo B-100 in a South European population].PMID 15498441Read ↗

[Plasma lipoprotein (a) values in familial defective ligand apo B 100 in a South European population].Semantic proximity Read ↗

[Identification and characterization of the first Spanish familial ligand-defective apolipoprotein B homozygote].Semantic proximity Read ↗

Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.Semantic proximity Read ↗

Familial defective apolipoprotein B-100: a lesson from homozygous and heterozygous patients.Semantic proximity Read ↗

Familial defective apolipoprotein B100: clinical characteristics of 54 cases.Semantic proximity Read ↗

Familial defective apolipoprotein B-100: A review.Semantic proximity Read ↗

Familial defective apolipoprotein B-100 is clinically indistinguishable from familial hypercholesterolemia.Semantic proximity Read ↗

Characteristics of 46 heterozygous carriers and 57 unaffected relatives in five Danish families with familial defective apolipoprotein B-100.Semantic proximity Read ↗

Familial defective apolipoprotein B-100 in a group of hypercholesterolaemic patients in Poland. Identification of a new mutation Thr3492Ile in the apolipoprotein B gene.Semantic proximity Read ↗

Rare and common mutations in hyperlipidemia and atherosclerosis. With special reference to familial defective apolipoprotein B-100.Semantic proximity Read ↗

Familial ligand-defective apolipoprotein B-100: simultaneous detection of the ARG3500-->GLN and ARG3531-->CYS mutations in a French population.Semantic proximity Read ↗

Familial defective apolipoprotein B-100 in Slovakia: are differences in prevalence of familial defective apolipoprotein B-100 explained by ethnicity?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.